{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T04:10:09Z","timestamp":1790136609909,"version":"4.0.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,24]],"date-time":"2020-03-24T00:00:00Z","timestamp":1585008000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,3,24]],"date-time":"2020-03-24T00:00:00Z","timestamp":1585008000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Mitochondrial diseases (MD) are generally serious and progressive, inherited metabolic diseases. There is a high comorbidity of anxiety and depression and limitations in daily functioning. The complexity and duration of the diagnostic process and lack of knowledge about prognosis leads to uncertainty. In this study, we investigated the psychological well-being of children who are suspected for MD and their parents.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In total 122 children suspected for MD and their parents, received questionnaires as part of standard clinical investigation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Parent proxy report revealed a lower quality of life (QoL) compared to norms and even more physical problems compared to chronically ill patients. They also reported more behavioral problems in general and more internalizing problems compared to the norms. Most frequent reported somatic complaints were tiredness and pain. Parents did not report enhanced levels of stress regarding parenting and experienced sufficient social support. At the end of the diagnostic process, 5.7% of the children received the genetically confirmed diagnosis of MD, 26% showed non-conclusive abnormalities in the muscle biopsy, 54% did not receive any diagnosis, and the remaining received other diagnoses. Strikingly, children without a diagnosis showed equally QoL and behavioral problems as children with a diagnosis, and even more internalizing problems.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This study highlights the psychological concerns of children with a suspicion of MD. It is important to realize that as well as children with a confirmed diagnosis, children without a diagnosis are vulnerable since explanation for their complaints is still lacking.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13023-020-1342-8","type":"journal-article","created":{"date-parts":[[2020,3,24]],"date-time":"2020-03-24T12:02:50Z","timestamp":1585051370000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Psychological functioning in children suspected for mitochondrial disease: the need for care"],"prefix":"10.1186","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9030-8302","authenticated-orcid":false,"given":"Kim F. E.","family":"van de Loo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 A. E.","family":"Custers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saskia","family":"Koene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inge-Lot","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirian C. H.","family":"Janssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan A. M.","family":"Smeitink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christianne M.","family":"Verhaak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,24]]},"reference":[{"key":"1342_CR1","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.mito.2012.11.002","volume":"13","author":"S Koene","year":"2013","unstructured":"Koene S, Wortmann SB, de Vries MC, Jonckheere AI, Morava E, de Groot IJ, et al. Developing outcome measures for pediatric mitochondrial disorders: which complaints and limitations are most burdensome to patients and their parents? Mitochondrion. 2013;13:15\u201324.","journal-title":"Mitochondrion."},{"key":"1342_CR2","doi-asserted-by":"crossref","unstructured":"Parikh S, Goldstein A, Karaa A, Koenig MK, Anselm I, Brunel-Guitton C, et al. Patient care standards for primary mitochondrial disease: a consensus statement from the mitochondrial medicine society. Genet Med. 2017;19:1\u201318.","DOI":"10.1038\/gim.2017.107"},{"key":"1342_CR3","first-page":"115","volume":"2004","author":"AM Schaefer","year":"1659","unstructured":"Schaefer AM, Taylor RW, Turnbull DM, Chinnery PF. The epidemiology of mitochondrial disorders--past, present and future. Biochim Biophys Acta. 1659;2004:115\u201320.","journal-title":"Biochim Biophys Acta"},{"key":"1342_CR4","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1056\/NEJMra1012478","volume":"366","author":"WJ Koopman","year":"2012","unstructured":"Koopman WJ, Willems PH, Smeitink JA. Monogenic mitochondrial disorders. N Engl J Med. 2012;366:1132\u201341.","journal-title":"N Engl J Med"},{"key":"1342_CR5","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.cmet.2005.12.001","volume":"3","author":"JA Smeitink","year":"2006","unstructured":"Smeitink JA, Zeviani M, Turnbull DM, Jacobs HT. Mitochondrial medicine: a metabolic perspective on the pathology of oxidative phosphorylation disorders. Cell Metab. 2006;3:9\u201313.","journal-title":"Cell Metab"},{"key":"1342_CR6","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/gim.2014.177","volume":"17","author":"S Parikh","year":"2015","unstructured":"Parikh S, Goldstein A, Koenig MK, Scaglia F, Enns GM, Saneto R, et al. Diagnosis and management of mitochondrial disease: a consensus statement from the mitochondrial medicine society. Genet Med. 2015;17:689\u2013701.","journal-title":"Genet Med"},{"key":"1342_CR7","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.jad.2008.06.023","volume":"114","author":"S Koene","year":"2009","unstructured":"Koene S, Kozicz TL, Rodenburg RJ, Verhaak CM, de Vries MC, Wortmann S, et al. Major depression in adolescent children consecutively diagnosed with mitochondrial disorder. J Affect Disord. 2009;114:327\u201332.","journal-title":"J Affect Disord"},{"key":"1342_CR8","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.mito.2010.05.011","volume":"10","author":"E Morava","year":"2010","unstructured":"Morava E, Gardeitchik T, Kozicz T, de Boer L, Koene S, de Vries MC, et al. Depressive behaviour in children diagnosed with a mitochondrial disorder. Mitochondrion. 2010;10:528\u201333.","journal-title":"Mitochondrion."},{"key":"1342_CR9","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1177\/0883073813481622","volume":"28","author":"K Sofou","year":"2013","unstructured":"Sofou K. Mitochondrial disease: a challenge for the caregiver, the family, and society. J Child Neurol. 2013;28:663\u20137.","journal-title":"J Child Neurol"},{"key":"1342_CR10","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1053\/jpdn.2003.36","volume":"18","author":"CY Read","year":"2003","unstructured":"Read CY. The demands of biochemical genetic disorders: a survey of mothers of children with mitochondrial disease or phenylketonuria. J Pediatr Nurs. 2003;18:181\u20136.","journal-title":"J Pediatr Nurs"},{"key":"1342_CR11","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.apnr.2015.03.010","volume":"29","author":"BA Senger","year":"2016","unstructured":"Senger BA, Ward LD, Barbosa-Leiker C, Bindler RC. Stress and coping of parents caring for a child with mitochondrial disease. Appl Nurs Res. 2016;29:195\u2013201.","journal-title":"Appl Nurs Res"},{"key":"1342_CR12","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.pedn.2015.08.007","volume":"31","author":"BA Senger","year":"2016","unstructured":"Senger BA, Ward LD, Barbosa-Leiker C, Bindler RC. The parent experience of caring for a child with mitochondrial disease. J Pediatr Nurs. 2016;31:32\u201341.","journal-title":"J Pediatr Nurs"},{"key":"1342_CR13","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1097\/00005650-200108000-00006","volume":"39","author":"JW Varni","year":"2001","unstructured":"Varni JW, Seid M, Kurtin PS. PedsQL 4.0: reliability and validity of the Pediatric Quality of Life Inventory version 4.0 generic core scales in healthy and patient populations. Med Care. 2001;39:800\u201312.","journal-title":"Med Care"},{"key":"1342_CR14","volume-title":"Manual for the ASEBA Preschool Forms & Profiles","author":"TM Achenbach","year":"2000","unstructured":"Achenbach TM, Rescorla LA. Manual for the ASEBA Preschool Forms & Profiles. Burlington: University of Vermont Research Center for Children, Youth, & Families; 2000."},{"key":"1342_CR15","volume-title":"Manual for the ASEBA school-age forms and profiles","author":"TM Achenbach","year":"2001","unstructured":"Achenbach TM, Rescorla LA. Manual for the ASEBA school-age forms and profiles. Burlington: University of Vermont Research Center for Children, Youth, & Families; 2001."},{"key":"1342_CR16","volume-title":"NOSI, Nijmeegse ouderlijke stress index","author":"AJLL De Brock","year":"1992","unstructured":"De Brock AJLL, Vermulst AA, Gerris JRM, Abidin RR. NOSI, Nijmeegse ouderlijke stress index. Lisse: Swets & Zeitlinger; 1992."},{"key":"1342_CR17","first-page":"27","volume":"25","author":"R Van Dam-Baggen","year":"1992","unstructured":"Van Dam-Baggen R, Kraaimaat F. De inventarisatielijst sociale betrokkenheid (ISB): Een zelfbeoordelingslijst om sociale steun te meten. Gedragstherapie. 1992;25:27\u201346.","journal-title":"Gedragstherapie"},{"key":"1342_CR18","volume-title":"IRGL, invloed van reuma op gezondheid en leefwijze. Zelfbeoordelingslijst","author":"CJAE Huiskes","year":"2004","unstructured":"Huiskes CJAE, Kraaimaat FW, Bijlsma JWJ. IRGL, invloed van reuma op gezondheid en leefwijze. Zelfbeoordelingslijst. St Radboud, Nijmegen: Afdeling Medische Psychologie, Universitair Medisch Centrum; 2004."},{"key":"1342_CR19","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s11136-005-1388-z","volume":"15","author":"JW Varni","year":"2006","unstructured":"Varni JW, Burwinkle TM, Seid M. The PedsQL 4.0 as a school population health measure: feasibility, reliability, and validity. Qual Life Res. 2006;15:203\u201315.","journal-title":"Qual Life Res"},{"key":"1342_CR20","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/S0005-7967(97)00025-9","volume":"35","author":"AT Beck","year":"1997","unstructured":"Beck AT, Guth D, Steer RA, Ball R. Screening for major depression disorders in medical inpatients with the Beck depression inventory for primary care. Behav Res Ther. 1997;35:785\u201391.","journal-title":"Behav Res Ther"},{"key":"1342_CR21","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/s13023-018-0951-y","volume":"13","author":"JAE Custers","year":"2018","unstructured":"Custers JAE, de Laat P, Koene S, Smeitink J, Janssen MCH, Verhaak C. Fear of disease progression in carriers of the m.3243A > G mutation. Orphanet J Rare Dis. 2018;13:203.","journal-title":"Orphanet J Rare Dis"},{"key":"1342_CR22","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13023-016-0403-5","volume":"11","author":"C Verhaak","year":"2016","unstructured":"Verhaak C, de Laat P, Koene S, Tibosch M, Rodenburg R, de Groot I, et al. Quality of life, fatigue and mental health in patients with the m.3243A > G mutation and its correlates with genetic characteristics and disease manifestation. Orphanet J Rare Dis. 2016;11:25.","journal-title":"Orphanet J Rare Dis"},{"key":"1342_CR23","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1093\/jpepsy\/jsr042","volume":"36","author":"M Pinquart","year":"2011","unstructured":"Pinquart M, Shen Y. Behavior problems in children and adolescents with chronic physical illness: a meta-analysis. J Pediatr Psychol. 2011;36:1003\u201316.","journal-title":"J Pediatr Psychol"},{"key":"1342_CR24","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1093\/jpepsy\/16.4.411","volume":"16","author":"EC Perrin","year":"1991","unstructured":"Perrin EC, Stein RE, Drotar D. Cautions in using the child behavior checklist: observations based on research about children with a chronic illness. J Pediatr Psychol. 1991;16:411\u201321.","journal-title":"J Pediatr Psychol"},{"key":"1342_CR25","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1136\/jmedgenet-2018-105800","volume":"56","author":"S Parikh","year":"2019","unstructured":"Parikh S, Karaa A, Goldstein A, Bertini ES, Chinnery PF, Christodoulou J, et al. Diagnosis of 'possible' mitochondrial disease: an existential crisis. J Med Genet. 2019;56:123\u201330.","journal-title":"J Med Genet"},{"key":"1342_CR26","first-page":"53","volume-title":"Middle range theory for nursing","author":"MH Mishel","year":"2014","unstructured":"Mishel MH. Theories of uncertainty in illness. In: Smith MJ, Liehr PR, editors. Middle range theory for nursing. 3rd ed. New York: Springer Publishing Company, LLC; 2014. p. 53\u201386.","edition":"3"},{"key":"1342_CR27","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1750-1172-8-22","volume":"8","author":"M Anderson","year":"2013","unstructured":"Anderson M, Elliott EJ, Zurynski YA. Australian fmailies living with rare disease: experiences of diagnosis, health services use and needs for psychosocial support. Orphanet J rare dis. 2013;8:22.","journal-title":"Orphanet J rare dis"},{"key":"1342_CR28","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s13023-017-0622-4","volume":"12","author":"Y Zurynski","year":"2017","unstructured":"Zurynski Y, Deverell M, Dalkeuth T, Johnson S, Christodoulou J, Leonard H. Autstralian children living with rare diseases: experiences of diagnosis and perceived consequences of diagnostic delays. Orphanet J rare dis. 2017;12:86.","journal-title":"Orphanet J rare dis"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-020-1342-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13023-020-1342-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-020-1342-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,24]],"date-time":"2021-03-24T00:30:03Z","timestamp":1616545803000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-020-1342-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,24]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1342"],"URL":"https:\/\/doi.org\/10.1186\/s13023-020-1342-8","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,24]]},"assertion":[{"value":"4 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Present study does not fall within the remit of the Medical Research Involving Human Subjects Act (WMO). The study has been reviewed by the ethics committee on the basis of the Dutch Code of conduct for health research, the Dutch Code of conduct for responsible use, the Dutch Personal Data Protection Act and the Medical Treatment Agreement Act. The ethics committee has passed a positive judgment on the study.Patients received the questionnaires as standard care, the care as usual. No additional questionnaires were given for the aims of this study. No intervention was given.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"This study was not industry sponsored. KvdL, JC, SK, IK, MJ and CV report no disclosures. Prof. Jan Smeitink is the founding CEO of Khondrion BV.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"76"}}